312 related articles for article (PubMed ID: 23933981)
1. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.
Bittner S; Ruck T; Schuhmann MK; Herrmann AM; Moha ou Maati H; Bobak N; Göbel K; Langhauser F; Stegner D; Ehling P; Borsotto M; Pape HC; Nieswandt B; Kleinschnitz C; Heurteaux C; Galla HJ; Budde T; Wiendl H; Meuth SG
Nat Med; 2013 Sep; 19(9):1161-5. PubMed ID: 23933981
[TBL] [Abstract][Full Text] [Related]
2. TREK-king the blood-brain-barrier.
Bittner S; Ruck T; Fernández-Orth J; Meuth SG
J Neuroimmune Pharmacol; 2014 Jun; 9(3):293-301. PubMed ID: 24557892
[TBL] [Abstract][Full Text] [Related]
3. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
4. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
6. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
7. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
8. Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.
Lécuyer MA; Saint-Laurent O; Bourbonnière L; Larouche S; Larochelle C; Michel L; Charabati M; Abadier M; Zandee S; Haghayegh Jahromi N; Gowing E; Pittet C; Lyck R; Engelhardt B; Prat A
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E524-E533. PubMed ID: 28069965
[TBL] [Abstract][Full Text] [Related]
9. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation.
Samus M; Seelige R; Schäfer K; Sorokin L; Vestweber D
J Leukoc Biol; 2018 Oct; 104(4):787-797. PubMed ID: 29791026
[TBL] [Abstract][Full Text] [Related]
10. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.
Sagar D; Lamontagne A; Foss CA; Khan ZK; Pomper MG; Jain P
J Neuroinflammation; 2012 Oct; 9():245. PubMed ID: 23102113
[TBL] [Abstract][Full Text] [Related]
12. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
[TBL] [Abstract][Full Text] [Related]
13. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
14. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
15. West Nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model.
Roe K; Orillo B; Verma S
PLoS One; 2014; 9(7):e102598. PubMed ID: 25036379
[TBL] [Abstract][Full Text] [Related]
16. CD44 deficiency contributes to enhanced experimental autoimmune encephalomyelitis: a role in immune cells and vascular cells of the blood-brain barrier.
Flynn KM; Michaud M; Madri JA
Am J Pathol; 2013 Apr; 182(4):1322-36. PubMed ID: 23416161
[TBL] [Abstract][Full Text] [Related]
17. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Göbel K; Schuhmann MK; Pankratz S; Stegner D; Herrmann AM; Braun A; Breuer J; Bittner S; Ruck T; Wiendl H; Kleinschnitz C; Nieswandt B; Meuth SG
Eur J Immunol; 2014 Aug; 44(8):2295-305. PubMed ID: 24811005
[TBL] [Abstract][Full Text] [Related]
20. Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice.
Smith SS; Ludwig M; Wohler JE; Bullard DC; Szalai AJ; Barnum SR
Neurosci Lett; 2008 Sep; 442(2):158-60. PubMed ID: 18634851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
